India to United States: Atorvastatin Export Trade Route
India has recorded 3,749 verified shipments of Atorvastatin exported to United States, representing a combined trade value of $552.4M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $147.3K USD. The leading Indian exporter is PIRAMAL PHARMA LIMITED, which accounts for 42% of total export value with 369 shipments worth $230.9M USD. On the buying side, APOTEX CORP is the largest importer in United States with $237.0M USD in purchases. The top 3 suppliers — PIRAMAL PHARMA LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Atorvastatin corridor is one of India's established pharmaceutical export routes, with 3,749 shipments documented worth a combined $552.4M USD. The route is dominated by PIRAMAL PHARMA LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's atorvastatin manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $147.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 33.5%, placing it at rank #19 among India's top atorvastatin export destinations globally.
On the import side, key buyers of Indian atorvastatin in United States include APOTEX CORP, MYLAN PHARMACEUTICALS INC,, LIFESCIENCE LOGISTICS and 42 others. APOTEX CORP is the single largest importer with 450 shipments valued at $237.0M USD.
